ASX-listed MedAdvisor raises AU$9.5m from EBOS

Funding Rounds

▤ Summary

EBOS, a New Zealand and Australian-listed marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products that owns brands such as TerryWhite Chemmart, will gain 14.1 percent ownership of MedAdvisor as a result of the deal. Founded in 2010, MedAdvisor CEO Rob Read previously told ZDNet that its cloud-based medication management solution delivers efficiency gains to patients by allowing them to register and track prescriptions over time, as well as to order refills from their preferred pharmacies. MedAdvisor earlier this year launched its GP Link feature that connects patients with their doctor for medication management assistance including remote script renewal. MedAdvisor had also announced partnering with American health management and monitoring company iHealth Labs, whose MyVitals app was integrated into Apples HealthKit in late 2015. The former company said the agreement would allow Australian patients to be able to view results and metrics from iHealth devices through the MedAdvisor app, making it easier for users to manage all their health data in one location.

$ Funding

$
Amount $7.4M Total raised
□
Date October 24, 2017 Announcement date
◎
Investors MedAdvisor Lead investors
▥
Company http://www.medadvisor.com.au Funded company

▥ Classifications

industries
HealthTech
applications
No applications detected

◇ AskAI Classifications

Labels
SaaS Healthcare IT Pharmacy Management Software

▦ Linked Companies